AtriCure, Inc. (ATRC) Tops Q2 EPS by 9c

AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.10), $0.09 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.03 million.

For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c